BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3296129)

  • 1. A pitfall in the evaluation of medical therapy for occlusive arterial disease using the xenon wash-out technique.
    Jelnes R; Bülow J; Tønnesen KH
    Scand J Clin Lab Invest; 1987 May; 47(3):229-31. PubMed ID: 3296129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of subcutaneous adipose tissue blood flow in the ischaemic forefoot during 24 hours. Studies using the 133-xenon wash-out technique continuously over 24 hours.
    Jelnes R
    Dan Med Bull; 1988 Aug; 35(4):303-15. PubMed ID: 3048919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous adipose tissue blood flow in the forefoot during 24 hours. Labeling pattern and reproducibility.
    Jelnes R; Bülow J; Tønnesen KH
    Scand J Clin Lab Invest; 1987 May; 47(3):223-7. PubMed ID: 3589486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct determination of the tissue-to-blood partition coefficient for Xenon in human subcutaneous adipose tissue.
    Jelnes R; Rasmussen LB; Eickhoff JH
    Scand J Clin Lab Invest; 1984 Nov; 44(7):643-7. PubMed ID: 6531652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local regulation of subcutaneous blood flow and capillary filtration in limbs with occlusive arterial disease. Studies before and after arterial reconstruction.
    Eickhoff JH
    Dan Med Bull; 1986 Jun; 33(3):111-26. PubMed ID: 3720362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal foot blood flow in patients with arterial insufficiency.
    Jelnes R; Tønnesen KH
    Clin Sci (Lond); 1984 Jul; 67(1):89-95. PubMed ID: 6734081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The venous-arteriolar reflex].
    Krahenbuhl B; Bongard O
    J Mal Vasc; 1985; 10 Suppl A():53-6. PubMed ID: 4031684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forefoot vasoconstrictor response to increased venous pressure in normal subjects and in arteriosclerotic patients.
    Eickhoff JH
    Acta Chir Scand Suppl; 1980; 502():7-14. PubMed ID: 6941604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of raubasine (new formulation) in arterial occlusive diseases (author's transl)].
    Schütz RM; Teufel W; Glocke M
    Med Klin; 1976 Sep; 71(39):1605-10. PubMed ID: 790128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is non-specific aneurysmal disease of the infrarenal aorta also a peripheral microvascular disease?
    Midttun M; Sejrsen P; Paaske WP
    Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):625-9. PubMed ID: 10873731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External negative thigh pressure. Effect upon blood flow and pressure in the foot in patients with occlusive arterial disease.
    Agerskov K; Tofft HP; Jensen FB; Engell HC
    Dan Med Bull; 1990 Oct; 37(5):451-4. PubMed ID: 2272212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effects of nifedipine on calf and forefoot blood flow in patients with peripheral arterial insufficiency.
    Lorentsen E; Landmark K
    Angiology; 1983 Jan; 34(1):46-52. PubMed ID: 6824190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of gangrene during sleep.
    Jelnes R
    Scand J Clin Lab Invest; 1990 Jun; 50(4):351-61. PubMed ID: 2203138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the subcutaneous tissue to blood partition coefficient in patients with severe leg ischaemia by a double isotope washout technique.
    Bjerre-Jepsen K; Faris I; Henriksen O; Tønnesen KH
    Clin Physiol; 1982 Dec; 2(6):479-84. PubMed ID: 6891304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI; Edvinsson ML; Angus Deveber G
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why do patients with severe arterial insufficiency get pain during sleep?
    Jelnes R; Bülow J; Tønnesen KH; Lassen NA; Holstein P
    Scand J Clin Lab Invest; 1987 Nov; 47(7):649-54. PubMed ID: 3685867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome.
    Rustin MH; Grimes SM; Kovacs IB; Cooke ED; Bowcock SA; Sowemimo-Coker SO; Turner P; Kirby JD
    Eur J Clin Pharmacol; 1984; 27(1):61-5. PubMed ID: 6386490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal subcutaneous hyperaemia in the lower leg and foot of type 1 diabetic patients.
    Kastrup J; Sindrup JH; Christiansen E; Jelnes R; Wroblewski H; Nørgaard T; Parving HH
    Diabet Med; 1992; 9(1):38-43. PubMed ID: 1551308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experimental studies on pentoxifyllin in extremities with blood circulation disorders and in healthy extremities. Blood circulation measurements with xenol33-muscle-clearance, ultrasonic Doppler technic and rheography].
    Baumann JC
    Med Welt; 1975 Nov; 26(46):2103-6. PubMed ID: 1105053
    [No Abstract]   [Full Text] [Related]  

  • 20. The double isotope technique for in vivo determination of the tissue-to-blood partition coefficient for xenon in human subcutaneous adipose tissue--an evaluation.
    Jelnes R; Astrup A; Bülow J
    Scand J Clin Lab Invest; 1985 Oct; 45(6):565-8. PubMed ID: 4070957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.